Retrospective analysis of bevacizumab-induced arthralgia and clinical outcomes in ovarian cancer patients. Single center experience — Maria Kaparelou (2022) | RDL Network
Retrospective analysis of bevacizumab-induced arthralgia and clinical outcomes in ovarian cancer patients. Single center experience
Article 2022 en
Authors
MK
Maria Kaparelou
ML
Michalis Liontos
PK
Pelagia Katsimbri
Abstract
1 min read
Joint manifestations are common AEs in bevacizumab treated ovarian cancer patients and led to treatment discontinuation in 9% of the patients. However, this has not adversely affected the clinical outcome of the patients. Further research is needed for the appropriate management of these patients.
Maria Kaparelou, Roubini Zakopoulou, Anna Tsiara, Anastasios Kyriazoglou, Michalis Liontos, G. P. Tsironis, K. Koutsoukos, Flora Zagouri, Dimitrios‐Efthymios Vlachos, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis, Meletios A Dimopoulos, Aristotle Bamias
Nikolas Plevris, Pappa KI, G. Tsironis, M. Liontos, Ekatherina Charvalos, Alexandros Rodolakis, G. Vlachos, Meletios A Dimopoulos, Flora Zagouri, Paraskevi Apostolou, Irene Konstantopoulou, D Yanoukakos, Florentia Fostira
Georgia Agiostratidou, I. Sgouros, Eleni Galani, Athina Voulgari, Niki Chondrogianni, E. Samantas, Meletios A Dimopoulos, D. Skarlos, Efstathios S. Gonos
Discussion(0)
No comments yet. Be the first to comment.